Concepts (194)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Heart Failure | 13 | 2024 | 10896 | 2.010 |
Why?
|
| Diabetic Nephropathies | 3 | 2023 | 984 | 1.250 |
Why?
|
| Renal Insufficiency, Chronic | 6 | 2023 | 2200 | 1.240 |
Why?
|
| Acute Kidney Injury | 4 | 2022 | 1968 | 1.120 |
Why?
|
| Biphenyl Compounds | 4 | 2023 | 913 | 1.110 |
Why?
|
| Cardiovascular Diseases | 11 | 2023 | 15142 | 1.080 |
Why?
|
| Myocardial Infarction | 6 | 2023 | 11708 | 0.960 |
Why?
|
| Diabetes Mellitus, Type 2 | 9 | 2024 | 11729 | 0.940 |
Why?
|
| Hypertension | 10 | 2022 | 8480 | 0.860 |
Why?
|
| Ventricular Dysfunction, Left | 2 | 2022 | 2074 | 0.800 |
Why?
|
| Waist Circumference | 5 | 2015 | 917 | 0.720 |
Why?
|
| Coronary Artery Disease | 6 | 2023 | 6485 | 0.690 |
Why?
|
| Stroke Volume | 8 | 2024 | 5002 | 0.650 |
Why?
|
| Drug Combinations | 4 | 2023 | 1958 | 0.600 |
Why?
|
| Iran | 16 | 2015 | 709 | 0.590 |
Why?
|
| Dyslipidemias | 3 | 2022 | 851 | 0.580 |
Why?
|
| Angiotensin Receptor Antagonists | 4 | 2023 | 923 | 0.580 |
Why?
|
| Hyperlipoproteinemia Type II | 1 | 2020 | 375 | 0.520 |
Why?
|
| Drug-Eluting Stents | 1 | 2022 | 753 | 0.510 |
Why?
|
| Cardiovascular System | 1 | 2022 | 828 | 0.500 |
Why?
|
| Troponin T | 4 | 2023 | 754 | 0.490 |
Why?
|
| Natriuretic Peptide, Brain | 4 | 2023 | 1572 | 0.490 |
Why?
|
| Glomerular Filtration Rate | 4 | 2023 | 2167 | 0.470 |
Why?
|
| Wrist | 1 | 2014 | 223 | 0.430 |
Why?
|
| Long QT Syndrome | 1 | 2017 | 453 | 0.430 |
Why?
|
| Cardiology | 1 | 2023 | 1668 | 0.410 |
Why?
|
| Myocardial Ischemia | 1 | 2022 | 2150 | 0.400 |
Why?
|
| Perioperative Care | 1 | 2019 | 1002 | 0.400 |
Why?
|
| Hypoglycemic Agents | 1 | 2023 | 2877 | 0.390 |
Why?
|
| Obesity | 5 | 2022 | 12744 | 0.390 |
Why?
|
| Coronary Disease | 7 | 2014 | 6078 | 0.380 |
Why?
|
| Mutation, Missense | 1 | 2020 | 2566 | 0.380 |
Why?
|
| Atrial Natriuretic Factor | 2 | 2022 | 393 | 0.370 |
Why?
|
| Cardiomyopathies | 1 | 2022 | 1911 | 0.370 |
Why?
|
| Glucose | 3 | 2021 | 4398 | 0.350 |
Why?
|
| Waist-Hip Ratio | 4 | 2015 | 516 | 0.350 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2020 | 2916 | 0.350 |
Why?
|
| Risk Factors | 22 | 2022 | 72252 | 0.350 |
Why?
|
| Lipids | 4 | 2015 | 3307 | 0.340 |
Why?
|
| Stroke | 5 | 2022 | 9975 | 0.340 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2023 | 3338 | 0.330 |
Why?
|
| Creatinine | 3 | 2023 | 1918 | 0.330 |
Why?
|
| Humans | 55 | 2024 | 743811 | 0.320 |
Why?
|
| Thrombosis | 1 | 2022 | 2968 | 0.310 |
Why?
|
| Forecasting | 1 | 2017 | 2950 | 0.310 |
Why?
|
| Electrocardiography | 3 | 2017 | 6441 | 0.310 |
Why?
|
| Prognosis | 7 | 2023 | 29052 | 0.310 |
Why?
|
| Tetrazoles | 2 | 2023 | 834 | 0.290 |
Why?
|
| Diabetes Mellitus | 3 | 2022 | 5752 | 0.290 |
Why?
|
| Atherosclerosis | 1 | 2023 | 3445 | 0.290 |
Why?
|
| Risk Assessment | 5 | 2017 | 23327 | 0.280 |
Why?
|
| Heart Rate | 1 | 2017 | 4091 | 0.270 |
Why?
|
| Contrast Media | 4 | 2022 | 5301 | 0.270 |
Why?
|
| Ventricular Remodeling | 2 | 2022 | 1225 | 0.250 |
Why?
|
| Proportional Hazards Models | 8 | 2022 | 12354 | 0.250 |
Why?
|
| Blood Pressure | 4 | 2021 | 8551 | 0.240 |
Why?
|
| Antihypertensive Agents | 1 | 2014 | 2047 | 0.240 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2019 | 3255 | 0.240 |
Why?
|
| Population Surveillance | 1 | 2014 | 2614 | 0.230 |
Why?
|
| Glycosides | 1 | 2023 | 107 | 0.220 |
Why?
|
| Anterior Wall Myocardial Infarction | 1 | 2023 | 44 | 0.220 |
Why?
|
| Angiopoietin-2 | 1 | 2023 | 172 | 0.220 |
Why?
|
| Diabetic Cardiomyopathies | 1 | 2024 | 95 | 0.220 |
Why?
|
| Follow-Up Studies | 14 | 2017 | 39001 | 0.210 |
Why?
|
| Incidence | 11 | 2015 | 20948 | 0.210 |
Why?
|
| Tissue Inhibitor of Metalloproteinase-1 | 1 | 2022 | 148 | 0.210 |
Why?
|
| Natriuretic Peptides | 1 | 2023 | 150 | 0.200 |
Why?
|
| Ventricular Function, Left | 3 | 2024 | 3660 | 0.200 |
Why?
|
| Censuses | 1 | 2022 | 200 | 0.200 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 3 | 1 | 2023 | 424 | 0.200 |
Why?
|
| Cystatin C | 1 | 2022 | 249 | 0.190 |
Why?
|
| Interleukin-18 | 1 | 2022 | 249 | 0.190 |
Why?
|
| Anthropometry | 3 | 2014 | 1348 | 0.190 |
Why?
|
| Osteopontin | 1 | 2022 | 294 | 0.190 |
Why?
|
| C-Reactive Protein | 2 | 2022 | 3778 | 0.190 |
Why?
|
| American Heart Association | 2 | 2023 | 1057 | 0.180 |
Why?
|
| Prospective Studies | 14 | 2023 | 53250 | 0.180 |
Why?
|
| Fractional Flow Reserve, Myocardial | 1 | 2023 | 289 | 0.170 |
Why?
|
| Body Mass Index | 6 | 2015 | 12718 | 0.160 |
Why?
|
| Coronary Angiography | 4 | 2023 | 4576 | 0.160 |
Why?
|
| Troponin I | 1 | 2022 | 619 | 0.150 |
Why?
|
| Perioperative Period | 1 | 2019 | 256 | 0.150 |
Why?
|
| Coronary Stenosis | 1 | 2023 | 833 | 0.150 |
Why?
|
| Algorithms | 1 | 2017 | 13869 | 0.140 |
Why?
|
| Cholesterol | 3 | 2022 | 2922 | 0.140 |
Why?
|
| Angiography | 1 | 2022 | 1638 | 0.140 |
Why?
|
| Sex Distribution | 4 | 2014 | 2298 | 0.140 |
Why?
|
| Health Status | 2 | 2024 | 4031 | 0.140 |
Why?
|
| Nutrition Surveys | 1 | 2022 | 1660 | 0.130 |
Why?
|
| Cause of Death | 2 | 2017 | 3580 | 0.130 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2023 | 2017 | 0.130 |
Why?
|
| Female | 26 | 2024 | 380020 | 0.130 |
Why?
|
| Treatment Outcome | 7 | 2023 | 63042 | 0.130 |
Why?
|
| Bayes Theorem | 1 | 2023 | 2307 | 0.120 |
Why?
|
| Phenotype | 2 | 2023 | 16361 | 0.120 |
Why?
|
| Male | 24 | 2024 | 349776 | 0.120 |
Why?
|
| Age Distribution | 3 | 2014 | 2899 | 0.110 |
Why?
|
| Middle Aged | 21 | 2023 | 213241 | 0.110 |
Why?
|
| 25-Hydroxyvitamin D 2 | 1 | 2013 | 39 | 0.110 |
Why?
|
| California | 1 | 2017 | 1402 | 0.110 |
Why?
|
| Carbon Dioxide | 1 | 2017 | 1150 | 0.110 |
Why?
|
| Prehypertension | 1 | 2013 | 61 | 0.110 |
Why?
|
| Inflammation | 2 | 2022 | 10629 | 0.110 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2023 | 3510 | 0.110 |
Why?
|
| Glucose Metabolism Disorders | 1 | 2012 | 54 | 0.110 |
Why?
|
| Pedigree | 1 | 2020 | 4643 | 0.110 |
Why?
|
| Interleukin-6 | 1 | 2022 | 3208 | 0.100 |
Why?
|
| Calcifediol | 1 | 2013 | 166 | 0.100 |
Why?
|
| Plaque, Atherosclerotic | 1 | 2023 | 1518 | 0.100 |
Why?
|
| United States | 4 | 2023 | 69859 | 0.100 |
Why?
|
| Prevalence | 5 | 2022 | 15211 | 0.100 |
Why?
|
| Oxygen Consumption | 1 | 2017 | 1869 | 0.090 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2022 | 10940 | 0.090 |
Why?
|
| Hemorrhage | 1 | 2022 | 3458 | 0.090 |
Why?
|
| Cholesterol, HDL | 2 | 2014 | 1813 | 0.090 |
Why?
|
| Predictive Value of Tests | 5 | 2023 | 15067 | 0.090 |
Why?
|
| Exercise Test | 1 | 2017 | 2074 | 0.090 |
Why?
|
| National Health Programs | 1 | 2012 | 445 | 0.080 |
Why?
|
| Patient Readmission | 1 | 2023 | 3117 | 0.080 |
Why?
|
| Confidence Intervals | 1 | 2014 | 2971 | 0.080 |
Why?
|
| Triglycerides | 2 | 2014 | 2453 | 0.080 |
Why?
|
| Insulin | 1 | 2023 | 6584 | 0.080 |
Why?
|
| Health Status Indicators | 1 | 2014 | 970 | 0.080 |
Why?
|
| Longitudinal Studies | 1 | 2023 | 13980 | 0.070 |
Why?
|
| Cholesterol, LDL | 2 | 2014 | 2354 | 0.070 |
Why?
|
| Adult | 14 | 2017 | 213889 | 0.070 |
Why?
|
| Primary Prevention | 1 | 2014 | 1167 | 0.070 |
Why?
|
| Aged | 11 | 2024 | 163178 | 0.070 |
Why?
|
| Diabetes Complications | 1 | 2013 | 1360 | 0.070 |
Why?
|
| Analysis of Variance | 1 | 2014 | 6356 | 0.070 |
Why?
|
| Multivariate Analysis | 6 | 2014 | 12243 | 0.060 |
Why?
|
| Blood Glucose | 3 | 2014 | 6259 | 0.060 |
Why?
|
| Apoprotein(a) | 1 | 2023 | 18 | 0.060 |
Why?
|
| Vitamin D Deficiency | 1 | 2013 | 1342 | 0.060 |
Why?
|
| Comorbidity | 2 | 2015 | 10380 | 0.060 |
Why?
|
| Residence Characteristics | 1 | 2013 | 2050 | 0.060 |
Why?
|
| Apolipoproteins A | 1 | 2023 | 94 | 0.060 |
Why?
|
| Sex Characteristics | 1 | 2013 | 2583 | 0.060 |
Why?
|
| Survival Rate | 1 | 2017 | 12786 | 0.050 |
Why?
|
| Adiposity | 1 | 2012 | 1806 | 0.050 |
Why?
|
| Growth Differentiation Factors | 1 | 2023 | 98 | 0.050 |
Why?
|
| Hospitalization | 1 | 2022 | 10259 | 0.050 |
Why?
|
| Quality of Life | 1 | 2024 | 12788 | 0.050 |
Why?
|
| Health Surveys | 1 | 2012 | 4036 | 0.050 |
Why?
|
| Health Behavior | 1 | 2014 | 2634 | 0.050 |
Why?
|
| Apolipoproteins B | 1 | 2023 | 374 | 0.050 |
Why?
|
| Age Factors | 2 | 2014 | 18355 | 0.040 |
Why?
|
| Constriction, Pathologic | 1 | 2023 | 1108 | 0.040 |
Why?
|
| Insulin Resistance | 1 | 2013 | 3863 | 0.040 |
Why?
|
| Phospholipids | 1 | 2023 | 784 | 0.040 |
Why?
|
| Severity of Illness Index | 1 | 2017 | 15526 | 0.040 |
Why?
|
| Albuminuria | 1 | 2023 | 681 | 0.040 |
Why?
|
| Lipoprotein(a) | 1 | 2023 | 435 | 0.040 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2020 | 17439 | 0.040 |
Why?
|
| Hypertrophy, Left Ventricular | 1 | 2024 | 858 | 0.040 |
Why?
|
| Brain Ischemia | 1 | 2012 | 3264 | 0.040 |
Why?
|
| Oxidation-Reduction | 1 | 2023 | 2183 | 0.040 |
Why?
|
| Cohort Studies | 3 | 2014 | 40545 | 0.040 |
Why?
|
| Postoperative Complications | 1 | 2019 | 15281 | 0.040 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 1 | 2021 | 1108 | 0.030 |
Why?
|
| Models, Biological | 1 | 2012 | 9582 | 0.030 |
Why?
|
| Time Factors | 2 | 2014 | 40038 | 0.030 |
Why?
|
| Adolescent | 2 | 2020 | 85729 | 0.030 |
Why?
|
| Temperance | 1 | 2014 | 89 | 0.030 |
Why?
|
| Middle East | 1 | 2014 | 219 | 0.030 |
Why?
|
| Smoking | 3 | 2014 | 8984 | 0.030 |
Why?
|
| Aged, 80 and over | 2 | 2014 | 57744 | 0.030 |
Why?
|
| Odds Ratio | 2 | 2012 | 9848 | 0.020 |
Why?
|
| Immunoenzyme Techniques | 1 | 2013 | 1799 | 0.020 |
Why?
|
| Lipoproteins, HDL | 1 | 2014 | 640 | 0.020 |
Why?
|
| Kinetics | 1 | 2017 | 6476 | 0.020 |
Why?
|
| Blood Pressure Determination | 1 | 2013 | 633 | 0.020 |
Why?
|
| Asymptomatic Diseases | 1 | 2011 | 552 | 0.020 |
Why?
|
| Sex Factors | 2 | 2013 | 10394 | 0.020 |
Why?
|
| Area Under Curve | 1 | 2012 | 1654 | 0.020 |
Why?
|
| Demography | 1 | 2013 | 1653 | 0.020 |
Why?
|
| Cross-Sectional Studies | 3 | 2013 | 25032 | 0.020 |
Why?
|
| Logistic Models | 2 | 2013 | 13404 | 0.020 |
Why?
|
| Fasting | 1 | 2014 | 1590 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2014 | 77410 | 0.020 |
Why?
|
| Reference Values | 1 | 2012 | 4974 | 0.020 |
Why?
|
| Propensity Score | 1 | 2011 | 1781 | 0.020 |
Why?
|
| ROC Curve | 1 | 2012 | 3527 | 0.020 |
Why?
|
| Overweight | 1 | 2014 | 2371 | 0.010 |
Why?
|
| Body Weight | 1 | 2013 | 4670 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2023 | 20121 | 0.010 |
Why?
|
| Recurrence | 1 | 2011 | 8337 | 0.010 |
Why?
|
| Risk | 1 | 2012 | 9677 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2011 | 10251 | 0.010 |
Why?
|
| Exercise | 1 | 2014 | 5611 | 0.010 |
Why?
|
| Young Adult | 2 | 2013 | 56392 | 0.010 |
Why?
|
| Disease Progression | 1 | 2013 | 13273 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2013 | 21733 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2021 | 35409 | 0.010 |
Why?
|
Concepts
(194)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(21)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_